Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Precision Biosciences (DTIL) Interest Expenses (2019 - 2025)

Precision Biosciences (DTIL) has disclosed Interest Expenses for 6 consecutive years, with $348000.0 as the latest value for Q4 2025.

  • Quarterly Interest Expenses fell 11.22% to $348000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.4 million through Dec 2025, down 20.2% year-over-year, with the annual reading at $1.4 million for FY2025, 20.2% down from the prior year.
  • Interest Expenses for Q4 2025 was $348000.0 at Precision Biosciences, down from $362000.0 in the prior quarter.
  • The five-year high for Interest Expenses was $579000.0 in Q4 2023, with the low at $24000.0 in Q2 2021.
  • Average Interest Expenses over 5 years is $351421.1, with a median of $362000.0 recorded in 2025.
  • The sharpest move saw Interest Expenses soared 1142.86% in 2023, then tumbled 55.56% in 2024.
  • Over 5 years, Interest Expenses stood at $53000.0 in 2021, then soared by 816.98% to $486000.0 in 2022, then increased by 19.14% to $579000.0 in 2023, then plummeted by 32.3% to $392000.0 in 2024, then decreased by 11.22% to $348000.0 in 2025.
  • According to Business Quant data, Interest Expenses over the past three periods came in at $348000.0, $362000.0, and $358000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.